update desk

Upcoming Netflix docuseries focuses on story of Nazi guard John Demjanjuk

“The Devil Next Door” examines whether he really was “Ivan the Terrible” or if it was a case of mistaken identity, as well as covers the media frenzy around his case.

John Demjanjuk in Israel's Supreme Court in Jerusalem. Photo by Flash90.
John Demjanjuk in Israel's Supreme Court in Jerusalem. Photo by Flash90.

A new Netflix docuseries centers on the story of a retired Ukrainian-American autoworker in Cleveland who was accused of being “Ivan the Terrible,” one of the Holocaust’s most notorious SS guards.

In the 1980s, a group of Holocaust survivors claimed that John Demjanjuk, a family man and respected member of his community, had allegedly tortured and killed nearly 1 million Jewish prisoners as a Nazi death-camp guard in the Treblinka extermination camp during World War II. While he did serve as a guard, it remained questionable as to whether he was that guard.

He was arrested and extradited to Israel, where he stood trial for crimes against humanity.

He died at a senior home in Germany on March 17, 2012 at the age of 91.

The docuseries, “The Devil Next Door” examines whether Demjanjuk really was “Ivan the Terrible” or if it was a case of mistaken identity, as well as covers the media frenzy around his case. The series includes raw footage from Demjanjuk’s trial, in which he claimed he was innocent, and shows Holocaust survivors testifying on the stand.

The trailer was released on Wednesday. Its five episodes hit Netflix on Nov. 4.

You have read 3 articles this month.
Register to receive full access to JNS.

Just before you scroll on...

Israel is at war. JNS is combating the stream of misinformation on Israel with real, honest and factual reporting. In order to deliver this in-depth, unbiased coverage of Israel and the Jewish world, we rely on readers like you. The support you provide allows our journalists to deliver the truth, free from bias and hidden agendas. Can we count on your support? Every contribution, big or small, helps JNS.org remain a trusted source of news you can rely on.

Become a part of our mission by donating today
Topics
Comments
Thank you. You are a loyal JNS Reader.
You have read more than 10 articles this month.
Please register for full access to continue reading and post comments.